The Efficacy of Pramipexole, a Dopamine Receptor Agonist, as an Adjunctive Treatment in Treatment-Resistant Depression: An Open-Label Trial
Dopaminergic dysfunction is implicated in the pathophysiology of treatment-resistant depression. Although the efficacy of adjunctive pramipexole treatment has been demonstrated in treatment-resistant bipolar depression, such data are scarce for major depressive disorder (MDD). We recruited 17 patien...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Scientific World Journal
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415165/ |